Montelukast Sodium Oral Soluble Film(Qilu Pharma)

孟鲁司特钠口溶膜(齐鲁制药)

Report date: 2025/07/15 15:32:38

Base Information

Drug NameMontelukast Sodium Oral Soluble Film(Qilu Pharma)
Drug Alias NameRomilast孟鲁斯特钠Montelukastum茂仑司特钠Montegen +[9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCysteinyl leukotriene receptor 1 antagonists
TargetsCysteinyl leukotriene receptor 1
Therapy Area/IndicationsRhinitis, AllergicAsthma
Global Approved IndicationsRhinitis, AllergicAsthma
Approved Indications in ChinaRhinitis, AllergicAsthma
Original Approved Country/TerritoryMainland China
Original Approved Date2021/03/09
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesQilu Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsRhinitis, AllergicAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A